Switzerland· 61533003
Anastrozol Zentiva
A anastrozole product, registered in Switzerland and dispensed under Swissmedic category B, on the national reimbursement list. The same ATC class is registered in 18 of our 19 countries.
Checked against BAG Spezialitätenliste (Switzerland) on
Informational only — not a medical device.
Where it is registered
Anastrozole is registered in 18 of 19 countries.
Countries holding a registration under ATC L02BG03 (anastrozole), each read from that country’s own register.
- This record: Switzerland, from BAG Spezialitätenliste (Switzerland)
- 11 of them publish a price we can compare per daily dose
Anastrozole · ATC L02BG03
18 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of anastrozole costs, country by country.
Normalised to the WHO defined daily dose (1 mg), the median price runs from $0.92 in France to $2.91 in Switzerland — a ×3.2 gap.
- Switzerland: $2.91 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
Anastrozole · price per daily dose (1 mg)
USD · FX 28 Sept 2026
- CH Switzerland$2.91
- IT Italy$1.46
- FR France$0.92
The record
At a glance
BAG Spezialitätenliste (Switzerland)- Manufacturer
- —
- Country
- Switzerland (CH)
- ATC code
- L02BG03
- ATC class
- Anastrozole
- Defined daily dose
- 1 mg, O
- Swissmedic category
- B
- Reimbursed
- Yes
- Source register
- BAG Spezialitätenliste (Switzerland)
- Last checked
- June 4, 2026
Packs & prices · 1
1 priced- gtin7680615330032Blist 28 StkCHF 73.45
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
174 interactions on record for anastrozole.
Graded by severity as the source publishes them — 1 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Anastrozole · interactions on record
174 records
- 1 severe
- 19 moderate
- 154 info
Most severe, free to view
- ThalidomideL04AX02severe
- FostamatinibB02BX09moderate
- EstradiolD11AX34moderate
- Levonorgestrel and ethinylestradiolG03AA07moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under L02BG03
Anastrozole, as other registers publish it.
- CanadaACH-ANASTROZOLEACCORD HEALTHCARE INC
- ItalyADIUNASTROLWAVE PHARMA S.R.L.
- CanadaAG-ANASTROZOLEANGITA PHARMA INC.
- IrelandAgerdex 1 mg film-coated tabletsViatris Limited
- CzechiaALOZEXGlenmark Pharmaceuticals s.r.o., Praha
- CzechiaALOZEXGlenmark Pharmaceuticals s.r.o., Praha
- CzechiaALOZEXGlenmark Pharmaceuticals s.r.o., Praha
- CzechiaALOZEXGlenmark Pharmaceuticals s.r.o., Praha
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of BAG Spezialitätenliste (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/dfe7aeec-c51c-456a-bd70-9f5673083fb3 GET /v1/drugs/dfe7aeec-c51c-456a-bd70-9f5673083fb3?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"unit": null,
"strength": "anastrozolum 1 mg",
"valid_from": "2023-01-01",
"limitations": null,
"galenic_form": "Filmtabl 1 mg",
"therapeutic_area": null,
"sl_inclusion_date": "2011-07-01",
"self_retention_pct": 10
}See everything about anastrozole.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.